Accès ouvert
2026
article
OpenAlex
Pieter Colin, Efthymios Manolis, Jeroen V. Koomen
Evidence generation for antihyperglycemic therapies in pediatric type 2 diabetes mellitus (T2DM) remains challenging, with most randomized trials failing to demonstrate statistically significant reductions in glycated hemoglobin (HbA1c), partly due to substantial between-subject variability. To better understand the sources and implications of …
nl
(code pays fourni par la source)
2026
article
OpenAlex
Loes Maton, Beatrijs I. Valk, Michel Struys, Jeroen V. Koomen et autres
nl, be
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Douglas J. Eleveld, Jeroen V. Koomen, Jasper Stevens, Pieter Colin et autres
Mixed effects models are a backbone of pharmacometrics, and NONMEM software, with the first-order conditional method with interaction having become the de facto industry standard for model estimation. Documentation exists for the general mathematical methodology for estimation, but many technical and implementation …
nl
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
D. Esther Lubberts, Douglas J. Eleveld, Laurens F. M. Verscheijden, Pieter Colin et autres
Long-acting injectable medicinal products (LAIs) prolong drug release and thereby aim to enhance adherence and patient outcomes. European regulatory guidelines require the conduct of single- and multiple-dose trials to exclude differences in drug release between non-steady and steady state conditions. The complexity …
nl
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Michele Introna, Carla Carozzi, Andrea Gentile, Riccarda Girasole et autres
Target-controlled infusion (TCI) systems, originally developed for intravenous drug administration of anesthetic drugs, enable precise drug delivery based on pharmacokinetic-pharmacodynamic (PKPD) models. While widely used in the operating room, their application in the intensive care unit (ICU) remains limited despite the complexity …
nl, it, be
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jeroen V. Koomen, Floris Vanommeslaeghe, Sigurd Delanghe, Wim Van Biesen et autres
BACKGROUND AND OBJECTIVE: End-stage kidney disease (ESKD) patients undergoing haemodialysis (HD) require a dosing regimen that balances the low endogenous clearance with the additional dialyser clearance. This study aimed to expand a previously proposed general-purpose pharmacokinetic model for piperacillin/tazobactam with a new …
nl, be
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Pieter Colin, Lynn H. Bichajian, Valentin Curt, Jeroen V. Koomen et autres
BACKGROUND: Remimazolam is not approved for use in pediatric patients. The pharmacokinetics of remimazolam have been reported to be similar to those of adult patients after scaling for body size. This article reports on the pharmacokinetics and pharmacodynamics of pediatric patients aged …
nl, us, de, be
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Douglas J. Eleveld, Pieter Colin, Johannes P. van den Berg, Jeroen V. Koomen et autres
BACKGROUND: Pharmacokinetic-pharmacodynamic (PK-PD) models of remimazolam and their covariate relationships are useful for understanding drug disposition and predicting drug effects. Although clinical studies have shown that remimazolam induction doses decline with advancing age, this property is not reflected in existing models. The …
nl, de
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Charlotte W. M. Simons, Maaike van Dartel, Michiel van den Heuvel, Loes den Otter et autres
AIMS: For new medicines, drug companies obtain regulatory approval on the strategy to generate evidence in the paediatric population, which can be supported by extrapolation of evidence obtained in a reference population. This study investigated whether paediatric marketing authorization applications (PMAAs) supported …
nl
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Remco Vellinga, Jeroen V. Koomen, Douglas J. Eleveld, Thomas Stöhr et autres
BACKGROUND: Synergistic effects between opioids and remimazolam on Bispectral Index (BIS) and Modified Observer's Assessment of Alertness and Sedation (MOAAS) score were previously described. This study aimed to characterize the influence of remifentanil on the sedative properties of remimazolam as measured by …
nl, de, be
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Daming Kong, Jason A. Roberts, Jeffrey Lipman, Fabio Silvio Taccone et autres
The pharmacokinetics (PK) of piperacillin/tazobactam (PIP/TAZ) is highly variable across different patient populations and there are controversies regarding non-linear elimination as well as the fraction unbound of PIP ( f UNB_PIP ). This has led to a plethora of subgroup-specific models, increasing …
nl, au, fr, be, us, th, gb, de, ca
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Yingxue Li, Jeroen V. Koomen, Douglas J. Eleveld, Johannes P. van den Berg et autres
Intraoperation hypotension (IOH) is commonly observed in patients undergoing surgery under general anesthesia, and even a brief episode of IOH can lead to unfavorable outcomes. To reduce the risk, blood pressure is closely measured during general anesthesia, and norepinephrine (NE) is frequently …
nl
(code pays fourni par la source)